HIGH RISK ACUTE MYELOID LEUKEMIA
Clinical trials for HIGH RISK ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for HIGH RISK ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell addback aims to slash infection risk in child stem cell recipients
Disease control Recruiting nowThis study tests whether adding a specific type of immune cell (memory T cells) after a stem cell transplant can help prevent serious viral and fungal infections. About 100 children and young adults with blood cancers, immune disorders, or bone marrow failure will receive this ex…
Matched conditions: HIGH RISK ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether adding venetoclax to the standard chemotherapy given before a stem cell transplant can help prevent the cancer from coming back in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 participants aged 12 to 60 …
Matched conditions: HIGH RISK ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Immune cell boost may keep leukemia at bay after transplant
Disease control Recruiting nowThis study tests whether giving patients special immune cells (γδ T cells) from a donor can help prevent their high-risk acute myeloid leukemia from returning after a stem cell transplant. About 40 adults aged 18 to 65 will receive the cell infusion and be monitored for safety an…
Matched conditions: HIGH RISK ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Phone app aims to ease emotional toll of leukemia treatment
Symptom relief Recruiting nowThis study tests a self-guided digital app called DREAMLAND to see if it can improve quality of life and emotional well-being for adults with acute myeloid leukemia (AML) who are receiving intensive chemotherapy. About 200 participants will use either DREAMLAND or a standard well…
Matched conditions: HIGH RISK ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 08:32 UTC